𝔖 Bobbio Scriptorium

✦ LIBER ✦

Phase IV study to evaluate the safety and efficacy of efalizumab for treatment of hand and foot psoriasis

Book ID: 116582348
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 49 KB
Volume: 56
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2006.10.262

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An open-label study to evaluate the safe

An open-label study to evaluate the safety and efficacy of 1.0 mg/kg subcutaneously administered efalizumab in adults with moderate to severe hand or foot psoriasis

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Efalizumab in the treatment of psoriasis

Efalizumab in the treatment of psoriasis: mode of action, clinical indications, efficacy, and safety

✍ Michael P. Schön 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 150 KB

A phase IV randomized, double-blind, pla

A phase IV randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of efalizumab in patients with moderate to severe plaque psoriasis involving the scalp

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Efficacy and safety of efalizumab for na

Efficacy and safety of efalizumab for nail psoriasis: Results of an open-label, multicenter study

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Efficacy and safety of efalizumab in adu

Efficacy and safety of efalizumab in adults with moderate to severe plaque psoriasis and hand and foot involvement: A prospective, 24-week, open-label phase IIIb/IV clinical trial in patients from Latin America

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Efficacy and safety of efalizumab in pat

Efficacy and safety of efalizumab in patients with chronic moderate to severe plaque psoriasis: Results from a postapproval phase IIIb/IV study (control II)

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB